Opioid complications and side effects.
Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R.
Pain Physician. 2008 Mar;11(2 Suppl):S105-20.
The role of hormones in muscle hypertrophy.
Fink J, Schoenfeld BJ, Nakazato K.
Phys Sportsmed. 2018 Feb;46(1):129-134. doi: 10.1080/00913847.2018.1406778. Epub 2017 Nov 25.
Mortality Among Users of Anabolic Steroids.
Windfeld-Mathiasen J, Heerfordt IM, Dalhoff KP, Andersen JT, Horwitz H.
JAMA. 2024 Apr 9;331(14):1229-1230. doi: 10.1001/jama.2024.3180.
Current use and abuse of anabolic steroids.
Reyes-Vallejo L.
Actas Urol Esp (Engl Ed). 2020 Jun;44(5):309-313. doi: 10.1016/j.acuro.2019.10.011. Epub 2020 Feb 26.
Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review.
Piacentino D, Kotzalidis GD, Del Casale A, Aromatario MR, Pomara C, Girardi P, Sani G.
Curr Neuropharmacol. 2015 Jan;13(1):101-21. doi: 10.2174/1570159X13666141210222725.
The adverse reactions of anabolic steroid abuse.
Windfeld-Mathiasen J, Christoffersen T, Horwitz H.
Ugeskr Laeger. 2022 Nov 14;184(46):V06220373.
Anabolic steroids and cardiovascular morbidity.
Windfeld-Mathiasen J, Horwitz H, Biering-Sørensen T, Olsen FJ.
Ugeskr Laeger. 2024 Oct 14;186(42):V04240260. doi: 10.61409/V04240260.
History and epidemiology of anabolic androgens in athletes and non-athletes.
Kanayama G, Pope HG Jr.
Mol Cell Endocrinol. 2018 Mar 15;464:4-13. doi: 10.1016/j.mce.2017.02.039. Epub 2017 Mar 1.
Anabolic androgenic steroid abuse in the United Kingdom: An update.
Mullen C, Whalley BJ, Schifano F, Baker JS.
Br J Pharmacol. 2020 May;177(10):2180-2198. doi: 10.1111/bph.14995. Epub 2020 Mar 3.
The importance of translationally evaluating steroid hormone contributions to substance use.
Maher EE, Strzelecki AM, Weafer JJ, Gipson CD.
Front Neuroendocrinol. 2023 Apr;69:101059. doi: 10.1016/j.yfrne.2023.101059. Epub 2023 Feb 7.
